Smriti Prasad

Smriti Prasad

Auto-generated profile, based on publicly available information

Smriti Prasad

Fetal Medicine Unit, Department of Obstetrics and Gynaecology, St George's University Hospitals NHS Foundation Trust University of London London UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
FDFrancesco D'Antonio
Francesco D'Antonio
DMD. Marinceu
D. Marinceu
SPS. Prasad
S. Prasad
Asma KhalilAsma Khalil
Asma Khalil

1 July 2022 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PIP. Birol Ilter
P. Birol Ilter
SPS. Prasad
S. Prasad
MMM. A. Mutlu
M. A. Mutlu
ATA. B. Tekin
A. B. Tekin
POP. O'BRien
P. O'BRien
Asma KhalilAsma Khalil
Asma Khalil
Objective: There is little evidence related to the effects of the Omicron severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant on pregnancy outcomes, particularly in unvaccinated women. This study aimed to compare pregnancy outcomes of unvaccinated women infected with SARS‐CoV‐2 during the pre‐Delta, Delta and Omicron waves.Methods: This was a retrospective cohort study conducted at two tertiary care facilities: Sancaktepe Training and Research Hospital, Istanbul, Turkey, and St George's University Hospitals NHS Foundation Trust, London, UK. Included were women who tested positive for SARS‐CoV‐2 by real‐time reverse‐transcription polymerase chain reaction (RT‐PCR) during pregnancy, between 1 April 2020 and 14 February 2022. The cohort was divided into three periods according to the date of their positive RT‐PCR test: (i) pre‐Delta (1 April 2020 to 8 June 2021 in Turkey, and 1 April 2020 to 31 July 2021 in the UK), (ii) Delta (9 June 2021 to 27 December 2021 in Turkey, and 1 August 2021 to 27 December 2021 in the UK) and (iii) Omicron (after 27 December 2021 in both Turkey and the UK). Baseline data collected included maternal age, parity, body mass index, gestational age at diagnosis and comorbidities. The primary outcome was the need for oxygen supplementation, classified as oxygen support via nasal cannula or breather mask, non‐invasive mechanical ventilation with continuous positive airway pressure (CPAP) or high‐flow oxygen, mechanical ventilation with intubation, or extracorporeal membrane oxygenation (ECMO). Inferences were made after balancing of confounders, using an evolutionary search algorithm. Selected confounders were maternal age, body mass index and gestational age at diagnosis of infection.Results: During the study period, 1286 unvaccinated pregnant women with RT‐PCR‐proven SARS‐CoV‐2 infection were identified, comprising 870 cases during the pre‐Delta period, 339 during the Delta wave and 77 during the Omicron wave. In the confounder‐balanced cohort, infection during the Delta wave vs during the pre‐Delta period was associated with increased need for nasal oxygen support (risk ratio (RR), 2.53 (95% CI, 1.75–3.65); P < 0.001), CPAP or high‐flow oxygen (RR, 2.50 (95% CI, 1.37–4.56); P = 0.002), mechanical ventilation (RR, 4.20 (95% CI, 1.60–11.0); P = 0.003) and ECMO (RR, 11.0 (95% CI, 1.43–84.7); P = 0.021). The maternal mortality rate was 3.6‐fold higher during the Delta wave compared to the pre‐Delta period (5.3% vs 1.5%, P = 0.010). Infection during the Omicron wave was associated with a similar need for nasal oxygen support (RR, 0.62 (95% CI, 0.25–1.55); P = 0.251), CPAP or high‐flow oxygen (RR, 1.07 (95% CI, 0.36–3.12); P = 0.906) and mechanical ventilation (RR, 0.44 (95% CI, 0.06–3.45); P = 0.438) with that in the pre‐Delta period. The maternal mortality rate was similar during the Omicron wave and the pre‐Delta period (1.3% vs 1.3%, P = 0.999). The need for nasal oxygen support during the Omicron wave was significantly lower compared to the Delta wave (RR, 0.26 (95% CI, 0.11–0.64); P = 0.003). Perinatal outcomes were available for a subset of the confounder‐balanced cohort. Preterm birth before 34 weeks' gestation was significantly increased during the Delta wave compared with the pre‐Delta period (15.4% vs 4.9%, P < 0.001).Conclusions: Among unvaccinated pregnant women, SARS‐CoV‐2 infection during the Delta wave, in comparison to the pre‐Delta period, was associated with increased requirement for oxygen support (including ECMO) and higher maternal mortality. Disease severity and pregnancy complications were similar between the Omicron wave and pre‐Delta period. SARS‐CoV‐2 infection of unvaccinated pregnant women carries considerable risks of morbidity and mortality regardless of variant, and vaccination remains key. Miscommunication of the risks of Omicron infection may impact adversely vaccination uptake among pregnant women, who are at increased risk of complications related to SARS‐CoV‐2. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

3 August 2023 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
FDFrancesco D'Antonio
Francesco D'Antonio
NENashwa Eltaweel
Nashwa Eltaweel
SPSmriti Prasad
Smriti Prasad
MFMaria Elena Flacco
Maria Elena Flacco
Lamberto ManzoliLamberto Manzoli
Lamberto Manzoli
Asma KhalilAsma Khalil
Asma Khalil
Background: The optimal approach to prevent preterm birth (PTB) in twins has not been fully established yet. Recent evidence suggests that placement of cervical cerclage in twin pregnancies with short cervical length at ultrasound or cervical dilatation at physical examination might be associated with a reduced risk of PTB. However, such evidence is based mainly on small studies thus questioning the robustness of these findings. The aim of this systematic review was to determine the role of cervical cerclage in preventing PTB and adverse maternal or perinatal outcomes in twin pregnancies. Methods and findings: Key databases searched and date of last search: MEDLINE, Embase, and CINAHL were searched electronically on 20 April 2023. Eligibility criteria: Inclusion criteria were observational studies assessing the risk of PTB among twin pregnancies undergoing cerclage versus no cerclage and randomized trials in which twin pregnancies were allocated to cerclage for the prevention of PTB or to a control group (e.g., placebo or treatment as usual). The primary outcome was PTB <34 weeks of gestation. The secondary outcomes were PTB <37, 32, 28, 24 weeks of gestation, gestational age at birth, the interval between diagnosis and birth, preterm prelabor rupture of the membranes (pPROM), chorioamnionitis, perinatal loss, and perinatal morbidity. Subgroup analyses according to the indication for cerclage (short cervical length or cervical dilatation) were also performed. Risk of bias assessment: The risk of bias of the included randomized controlled trials (RCTs) was assessed using the Revised Cochrane risk-of-bias tool for randomized trials, while that of the observational studies using the Newcastle–Ottawa scale (NOS). Statistical analysis: Summary risk ratios (RRs) of the likelihood of detecting each categorical outcome in exposed versus unexposed women, and (b) summary mean differences (MDs) between exposed and unexposed women (for each continuous outcome), with their 95% confidence intervals (CIs) were computed using head-to-head meta-analyses. Synthesis of the results: Eighteen studies (1,465 twin pregnancies) were included. Placement of cervical cerclage in women with a twin pregnancy with a short cervix at ultrasound or cervical dilatation at physical examination was associated with a reduced risk of PTB <34 weeks of gestation (RR: 0.73, 95% CI [0.59, 0.91], p = 0.005 corresponding to a 16% difference in the absolute risk, AR), <32 (RR: 0.69, 95% CI [0.57, 0.84], p < 0.001; AR: 16.92%), <28 (RR: 0.54, 95% [CI 0.43, 0.67], 0.001; AR: 18.29%), and <24 (RR: 0.48, 95% CI [0.23, 0.97], p = 0.04; AR: 15.57%) weeks of gestation and a prolonged gestational age at birth (MD: 2.32 weeks, 95% [CI 0.99, 3.66], p < 0.001). Cerclage in twin pregnancy with short cervical length or cervical dilatation was also associated with a reduced risk of perinatal loss (RR: 0.38, 95% CI [0.25, 0.60], p < 0.001; AR: 19.62%) and composite adverse outcome (RR: 0.69, 95% CI [0.53, 0.90], p = 0.007; AR: 11.75%). Cervical cerclage was associated with a reduced risk of PTB <34 weeks both in women with cervical length <15 mm (RR: 0.74, 95% CI [0.58, 0.95], p = 0.02; AR: 29.17%) and in those with cervical dilatation (RR: 0.68, 95% CI [0.57, 0.80], p < 0.001; AR: 35.02%). The association between cerclage and prevention of PTB and adverse perinatal outcomes was exclusively due to the inclusion of observational studies. The quality of retrieved evidence at GRADE assessment was low. Conclusions: Emergency cerclage for cervical dilation or short cervical length <15 mm may be potentially associated with a reduction in PTB and improved perinatal outcomes. However, these findings are mainly based upon observational studies and require confirmation in large and adequately powered RCTs.

10 March 2022 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PIP. Birol Ilter
P. Birol Ilter
SPS. Prasad
S. Prasad
MBM. Berkkan
M. Berkkan
MMM. A. Mutlu
M. A. Mutlu
ATA. B. Tekin
A. B. Tekin
Asma KhalilAsma Khalil
Asma Khalil

25 September 2021 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
EKErkan Kalafat
Erkan Kalafat
SPSmriti Prasad
Smriti Prasad
PBPinar Birol
Pinar Birol
ATArzu Bilge Tekin
Arzu Bilge Tekin
AKAtilla Kunt
Atilla Kunt
Asma KhalilAsma Khalil
Asma Khalil

30 August 2023 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
FDFrancesco D'Antonio
Francesco D'Antonio
DMD. Marinceu
D. Marinceu
SPS. Prasad
S. Prasad
NEN. Eltaweel
N. Eltaweel
Asma KhalilAsma Khalil
Asma Khalil
Objective: The published literature reports mostly on the outcome of twin pregnancies complicated by twin–twin transfusion syndrome (TTTS) without considering whether the pregnancy is also complicated by another pathology, such as selective fetal growth restriction (sFGR). The aim of this systematic review was to report on the outcome of monochorionic diamniotic (MCDA) twin pregnancies undergoing laser surgery for TTTS that were complicated by sFGR and those not complicated by sFGR.Methods: MEDLINE, EMBASE and Cochrane databases were searched. The inclusion criteria were studies reporting on MCDA twin pregnancies with TTTS undergoing laser therapy that were complicated by sFGR and those not complicated by sFGR. The primary outcome was the overall fetal loss following laser surgery, defined as miscarriage and intrauterine death. The secondary outcomes included fetal loss within 24 h after laser surgery, survival at birth, preterm birth (PTB) prior to 32 weeks of gestation, PTB prior to 28 weeks, composite neonatal morbidity, neurological and respiratory morbidity, and survival free from neurological impairment. All outcomes were explored in the overall population of twin pregnancies complicated by sFGR vs those not complicated by sFGR in the setting of TTTS and in the donor and recipient twins separately. Random‐effects meta‐analysis was used to combine data and the results are reported as pooled odds ratios (OR) with 95% CI.Results: Five studies (1710 MCDA twin pregnancies) were included in the qualitative synthesis and four in the meta‐analysis. The overall risk of fetal loss after laser surgery was significantly higher in MCDA twin pregnancies with TTTS complicated by sFGR (20.90% vs 14.42%), with a pooled OR of 1.6 (95% CI, 1.3–1.9) (P < 0.001). The risk of fetal loss was significantly higher in MCDA twin pregnancies with TTTS and sFGR for the donor but not for the recipient twin. The rate of live twins was 79.1% (95% CI, 72.6–84.9%) in TTTS pregnancies with sFGR and 85.6% (95% CI, 81.0–89.6%) in those without sFGR (pooled OR, 0.6 (95% CI, 0.5–0.8)) (P < 0.001). There was no significant difference in the risk of PTB prior to 32 weeks of gestation (P = 0.308) or prior to 28 weeks (P = 0.310). Assessment of short‐ and long‐term morbidity was affected by the small number of cases. There was no significant difference in the risk of composite (P = 0.506) or respiratory (P = 0.531) morbidity between twins complicated by TTTS with vs those without sFGR, while the risk of neurological morbidity was significantly higher in those with TTTS and sFGR (pooled OR, 1.8 (95% CI, 1.1–2.9)) (P = 0.034). The risk of neurological morbidity was significantly higher for the donor twin (pooled OR, 2.4 (95% CI, 1.1–5.2)) (P = 0.029) but not for the recipient twin (P = 0.361). Survival free from neurological impairment was observed in 70.8% (95% CI, 45.0–91.0%) of twin pregnancies with TTTS complicated by sFGR and in 75.8% (95% CI, 51.9–93.3%) of those not complicated by sFGR, with no difference between the two groups.Conclusions: sFGR in MCDA pregnancies with TTTS represents an additional risk factor for fetal loss following laser surgery. The findings of this meta‐analysis may be useful for individualized risk assessment of twin pregnancy complicated by TTTS and tailored counseling of the parents prior to laser surgery. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.